Estimates Revisions Abbott Laboratories Buenos Aires S.E.

Stocks

End-of-day quote Buenos Aires S.E. 06/10/2026			5-day change	1st Jan Change
39,500.00 ^ARS	-1.89%		-3.04%	-17.33%

10-05	Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities	CI
10-05	Abbott Laboratories Receives FDA Approval to Include Interactive Features in CardioMEMS Heart Monitor	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	ABBOTT LABORATORIES
	MEDTRONIC PLC
	STRYKER CORPORATION
	ESSILORLUXOTTICA
	CENCORA, INC.
	HOYA CORPORATION
	BECTON, DICKINSON AND COMPANY
	IDEXX LABORATORIES, INC.
	DEXCOM, INC.
	Average
	Weighted average by Cap.